GentiBio
PrivateLast Round
Series A
Aug 11, 2021
Total Funding Raised
$177M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GentiBio is a biotechnology company that develops engineered regulatory T-cell (EngTreg) therapies to restore immune tolerance and treat autoimmune, alloimmune, autoinflammatory, and allergic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GentiBio Comparables
Compare GentiBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quell Therapeutics | 87% | |
| Sonoma Biotherapeutics | 86% | |
| Mozart Therapeutics | 86% | |
GentiBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 11, 2021 | ||||
| Seed | Aug 5, 2020 |
Key People
Founding team and executive leadership
GentiBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A, Seed |
| Avidity Partners | Series A |
| OrbiMed | Series A, Seed |
| Matrix Capital Management | Series A |
| JDRF | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2026
Will present new data on engineered Treg therapy at the PES Annual Meeting.
- Apr 29, 2026
New data on GNTI-122 Treg therapy to be presented at medical conference.
GentiBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GentiBio's valuation, stock price, and market status.